Looking Into Strongbridge Biopharma's Return On Capital Employed

Retrieved on: 2021-05-27 15:07:18

Tags for this article:

Click the tags to see associated articles and topics

Looking Into Strongbridge Biopharma's Return On Capital Employed. View article details on hiswai:

Excerpt

Strongbridge Biopharma (NASDAQ:SBBP) reported Q1 sales of $8.38 million. Earnings fell to a loss of $10.07 million, resulting in a 3.15% decrease ...

Article found on: www.benzinga.com